| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |